Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 20 | 15 | −5 |
| Shares | 116.4K | 97.2K | −19.3K (−16.5%) |
| Value | $123.7K | $131.0K | +$7.30K (+5.9%) |
New holders (1)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 73 | $99 | 0.00% |
Sold out (6)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 13,280 | $14.0K |
| Two Sigma Securities, LLC | 12,870 | $13.6K |
| National Bank of Canada | 20 | $21 |
| Milestone Investment Advisors LLC | 1 | $2 |
| Farther Finance Advisors, LLC | 2 | $2 |
| Royal Bank of Canada | 69 | $0 |